Dexmethylphenidate controlled release(Cingulate Therapeutics)

N/A

Report date: 2025/10/20 17:59:05

Base Information

Drug NameDexmethylphenidate controlled release(Cingulate Therapeutics)
Drug Alias NameCTX-1301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonistsNorepinephrine transporter inhibitorsNeurokinin 1 receptor antagonists
TargetsDopamine transporterNorepinephrine transporterNeurokinin 1 receptor
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesCingulate Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCingulate Therapeutics IncCingulate Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A